AMYRIS - Key Persons
Job Titles:
- Chairman of the Nominating and Governance Committee
- Member of the Audit Committee
- Member of the Board of Directors
- CEO, Business Advisor and Corporate Board Director
- Member of Committee
Ms. Dutra serves as Director on the boards of the CME Group, Eletropar and First Internet Bank Bancorp.
Ana Dutra is an experienced CEO, business advisor and corporate board director of publicly-traded, family-owned and private corporations. She is a Latina leader with over 30 years of experience in P&L management, deals structuring, digital technology, business growth and C-Level business advisory in over 25 countries. She has deep experience in ESG, digital technology, e-commerce, ERP systems and has a CERT Certification in Cybersecurity Oversight by Carnegie Mellon University and the National Association of Corporate Directors.
Ms. Dutra serves as Director on the boards of the CME Group, Eletropar and First Internet Bancorp.
As a CEO, Ms. Dutra has led several global and cross-border acquisitions, joint-ventures, partnership agreements and M&A integrations. In her own tenure as CEO and P&L leader with companies such as IBM, CSC, Marsh & McLennan, Accenture and Korn/Ferry International, Ms. Dutra created several $500+ MM global businesses through the combination of organic growth, global acquisitions and joint-ventures, innovative go-to-market approaches and incorporation of technology and digital transformation of services and products.
Ms. Dutra holds an MBA from Kellogg at Northwestern University, a Masters in Economics from Pontificia Universidade do Rio de Janeiro, a Juris Doctor from Universidade do Estado do Rio de Janeiro.
Member of the Leadership, Development, Inclusion and Compensation Committee & Nominating and Governance Committee
Job Titles:
- Chief Strategy and Product Officer
- Chief Strategy Officer & Product & Ingredients
Annie Tsong was appointed Chief Strategy and Product Officer in 2021 and is responsible for developing Amyris' extensive pipeline of products and ingredients. She maintains the strategic portfolio by identifying the intersection between market needs and areas where Amyris' technology offers new value.
A long-time Amyris veteran, Annie joined Amyris in 2008 in the Research and Development division, where she was central in establishing the company's foundational microbial production platform. Subsequently, she established a Program Management Office which brought Amyris' highest priority molecules to market by integrating activity across capabilities from upstream R&D to commercialization. Most recently, Annie turned her attention to Product Innovation, where her team established an ingredient development pipeline focused on fast-to-market opportunities that support Amyris' strategic objectives. Annie has authored multiple landmark scientific publications in the fields of metabolic engineering and evolution of transcriptional regulation. She is an inventor on many key patents in Amyris' IP portfolio, and a frequent speaker at international scientific conferences.
Annie holds an AB in Biochemical Sciences from Harvard University, a Ph.D. in genetics from University of California, San Francisco, and was a Miller Fellow at University of California, Berkeley.
Job Titles:
- CEO, Rose Inc and Head of Product Innovation
- Senior Vice President, Personal Care
Caroline Hadfield joined Amyris in June 2015 as Senior Vice President, Personal Care, and led the company's B2B and B2C sales initiatives for its consumer cosmetic products through a period of significant growth and was appointed President of the company's Biossance clean skincare brand she created and developed, as well as President of the company's Aprinnova skincare ingredients business in July 2018. She continued the rapid growth of both divisions, developing the company's focus on Clean Beauty, and pioneering the movement to ban toxic ingredients and introduced sustainable packaging and clinically tested formulations for maximum efficacy. In February 2019, she was appointed to lead the company's new direct-to-consumer baby and family skincare brand, Pipette, to launch a new range of clean beauty products focused on baby, mothers and family, which has grown significantly since its launch in September 2019 and is well placed for continued rapid expansion. As an expert in originating, building and running brands she has been essential in launching and managing the growth of brands while introducing innovative new product lines and building out robust ecommerce and bricks-and-mortar sales channels. She led the Aprinnova B2B ingredients business with a keen view on new opportunities to bring product innovation and exceptional brands to Amyris through her entrepreneurial expertise and exceptional success as a high-growth brand executive. In 2020, Caroline became Chief Executive Officer of Rose Inc., a new business venture focused on Clean Beauty color cosmetics, that will launch in 2021.
Previously, Hadfield owned and operated an established retail consultancy practice specializing in the health, wellness and the personal care market sectors. Prior to that, she cofounded luxury spa interests in the United Kingdom and San Francisco where she developed branded spa products and also served as Global Product Director for Bodyshop International, where she was responsible for a complete range of globally sourced and regionally targeted products and contributed extensively to marketing strategy and packaging design. Before joining Bodyshop, Hadfield was Senior Vice President at Sephora (part of LVMH Group) and was part of the executive team that rolled out the Sephora concept across the U.S., opening 50 stores within just 18 months. Her experience also includes prior roles in merchandizing as SVP - General Merchandise Manager with Duty Free Shoppers (part of LVMH) and as Buying Controller with Burton Group (now Arcadia). Hadfield holds a Bachelor of Arts (Honours) degree in textiles and management from Leeds University and has completed a Senior Executive Program at Stanford University.
Job Titles:
- President of Biossance and JVN Hair
- President, Biossance
Catherine is the President of Biossance and JVN Hair at Amyris. Catherine joined Amyris in July 2018. Prior to joining, Catherine was the Global General Manager for the Kendo portfolio of beauty brands within LVMH, including Marc Jacobs Beauty, Kat von D, Disney and Ole Henriksen Skincare. Catherine built these brands from concept to development and launched them in over 22 countries. Prior to Kendo, Catherine spent over 15 years at Sephora, predominantly responsible for Sephora Collection, Sephora's private label brand. She led the brand re-design and product strategy that lifted Sephora Collection to the #1 brand at Sephora globally. As one of Sephora USA's first hires and member of EllesVMH (select group of high-performing female executives within LVMH), she helped shape and grow the Sephora organization into the beauty leader it is today. In 2019, WWD named Catherine Gore their "Beauty Futurist".
Gore holds a Bachelor of Arts degree in Communications/Business from St. Mary's College of California.
As Amyris Chief People Officer, Christine Ofori is responsible for leading and integrating all facets of Amyris's HR goals, including people strategy and enhancement of company culture in order to deliver and enable business growth. Christine brings many years of HR leadership experience to Amyris, including successful integration of people, technologies, processes and cultures. Most recently, Christine served as Vice President of Human Resources at Amyris where she guided all aspects of employee development, staffing and business partnering. Prior to that, she spent over eight years with Equinix, Inc. as Senior Director, Human Resources supporting the Americas Region. Christine studied Business at the University of Minnesota.
Job Titles:
- President, Healthy Aging
- Strategic and Accomplished Executive
Deb Millard is a strategic and accomplished executive with +20 years of brand and retail leadership experience across multiple categories. Deb joined Amyris as President, Healthy Aging at the end of 2021. Over the past year Deb has been focused on launching Amyris first healthy aging brand with the "No Compromise" mission to bring safe, effective solutions to the peri/menopause space alongside Naomi Watts. Deb's retail career started as a founding member of the US Sephora team bringing Sephora to the US market. Most recently, for the past +7 years, Deb served in various roles at Amazon leading retail and marketplace strategies for Amazon Fashion categories later moving to Amazon Go as the Category Leader/General Manager for Go and new formats under that umbrella. Prior to Deb's time at Amazon she helped Old Navy launch into the Canada Market, returned to Sephora to lead skincare in the rollout of Sephora inside JCP. She also held leadership roles at Williams-Sonoma, Restoration Hardware and owned her own retail and wholesale business in the SF Bay area.
Job Titles:
- Member of the Board of Directors
- Founding Member of Vivo
Dr. Kung is a founding member of Vivo, a healthcare/biotechnology venture capital management firm founded in 1996 in Palo Alto, California. Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation. He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983. In 1984 he co-founded Genelabs Technologies, Inc. where he served as Chairman and CEO until 1995. During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan. Dr. Kung holds a Bachelor of Science degree in chemistry from the National Tsing Hua University in Taiwan, and a Doctor of Philosophy degree in molecular biology and a Master of Business Administration degree from the University of California, Berkeley. Dr. Kung currently serves on the board of directors of a number of emerging healthcare and biotechnology companies.
Eduardo Alvarez joined Amyris as Chief Operating Officer in October 2017. He has over 30 years of global operations experience both running and advising growth companies. Previously, he served as Global Operations Strategy Leader for PwC. During his tenure, he co-led the integration of his prior company, Booz & Company, following its acquisition by PwC. In his role, he grew operations into a global practice with $1.5 billion in revenue and 4,000 employees. His assignments focused on delivering structural cost improvements while also driving sustained revenue growth. His experience also includes roles at Booz Allen Hamilton, General Electric and AT&T. Alvarez holds a Master of Business Administration from Harvard Business School, a Master of Science in Mechanical Engineering in computer control and manufacturing from the University of California, Berkeley, and a Bachelor of Science degree in mechanical engineering from the University of Michigan. He is a board member of The Chicago Council of Global Affairs.
Francisco Costa joined Amyris as Chief Creative Officer in March, 2021. Prior to his arrival at Amyris, Francisco spent 13 years as Creative Director of womenswear for Calvin Klein, working directly with Calvin Klein and with other top design houses such as Gucci, Balmain Couture, and Oscar de la Renta. Mr. Costa's first collection for the house debuted for Spring 2004.. After his departure from the brand in 2016, Costa, an avid environmentalist, returned to his home country of Brazil where he discovered local healing rituals and an untapped wealth of curative native ingredients in the Amazon rainforest.
After realizing quickly that there was an urgent need for conservation, Costa
launched Costa Brazil, an eco-forward skincare and fragrance line with products made from natural ingredients found in the Amazon rainforest. The brand works in partnership with local cooperatives and scientists, ensuring protection of both body and Earth.
Francisco Costa is engaged in numerous social causes in Brazil and around the world. He designed the logo for BrazilFoundation's #TeamRio campaign - an initiative raising awareness and funds for social projects in the city of Rio de Janeiro, at the occasion of the Olympic Games.
Job Titles:
- Member of the Audit Committee
- Member of the Board of Directors
- Member of the Leadership, Development, Inclusion and Compensation Committee & Nominating and Governance Committee
- Partner at Circularis Partners
Dr. Duyk is partner at Circularis Partners, an investment firm focused on supporting technology-enabled companies that advance the circular economy, promote sustainability, and enhance resource efficiency. Prior to Circularis, Dr. Duyk was the managing director and partner of TPG Alternative & Renewable Technologies (ART)/TPG Biotechnology from 2004 to 2017. Prior to joining TPG, Dr. Duyk served on the Board of Directors and was President of Research and Development at Exelixis. Prior to Exelixis, he was one of the founding scientific staff at Millennium Pharmaceuticals and served as Vice President of Genomics. Prior to his tenure at Millennium, Dr. Duyk was an Assistant Professor at Harvard Medical School (HMS) in the Department of Genetics, and an Assistant Investigator of the Howard Hughes Medical Institute (HHMI). While at HMS, Dr. Duyk was a Co-Principal Investigator in the National Institutes of Health (NIH) funded Cooperative Human Linkage Center. Dr. Duyk holds a Ph.D. and M.D. from Case Western Reserve University. He completed his medical and fellowship training at the University of California, San Francisco. While at UCSF, Dr. Duyk was a fellow of the Lucille P. Markey Foundation and was also awarded a post-doctoral fellowship from HHMI. He is a Fellow of the American Association for the Advancement of Science. Dr. Duyk currently serves on the Board of Directors of Anuvia Plant Nutrients; Concentric Ag; and Regen. He is a trustee of Case Western Reserve University where he Chairs the finance committee and is a member of the executive committee and investment committee. Dr. Duyk is also a member of the Institute Board of Directors of the Moffitt Cancer Center where he Chairs the R&D committee. He serves as Chairman of the Board of OncoBay Clinical, a private contract research organization and subsidiary of Moffitt Cancer Center. Dr. Duyk previously served on the Board of Directors of the American Society of Human Genetics (ASHG) where he is currently a member of the organization's finance committee and Chairs the investment committee. He is a member of the Scientific Advisory Board (SAB) for Lawrence Berkeley National Lab (DOE) and a member of the Advisory Board for Innovatus Capital Partners. Previously, he served as a member of the SAB for Bayer CropSciences, Jackson Labs, as well as numerous NIH advisory committees. Dr. Duyk serves or has served as an advisor (e.g. Qiming Ventures, Grove BioPharma, etc.) or board member to a number of seed stage biotechnology companies.
Han Kieftenbeld joined Amyris as Chief Financial Officer in March 2020 and was appointed Chief Administration Officer in July 2020. He brings over 30 years of international business leadership, finance and operations experience in food, health and nutrition end-markets. Most recently, from April 2016 to April 2019, Mr. Kieftenbeld served as Senior Vice President and Chief Financial Officer of Innophos Holdings, Inc., a leading international science-based producer of essential ingredients for health and nutrition, food and beverage and industrial brands. From June 2014 to July 2015, Mr. Kieftenbeld served as the Global Chief Financial Officer at AB Mauri, a worldwide leader in bakery ingredients. Prior to that, Mr. Kieftenbeld held finance and operations roles of increasing reach and impact, including serving as Global Chief Procurement Officer of Ingredion Incorporated, and Global Chief Financial Officer of National Starch. Mr. Kieftenbeld started his career at Unilever in the Netherlands. Mr. Kieftenbeld earned a joint master's degree from New York University Stern School of Business, London School of Economics and Political Science, and the HEC School of Management, Paris. He holds a B.S. in Business Economics and Accounting from Windesheim University in the Netherlands.
Job Titles:
- Chairman of the Board
- Founder
- Member of the Audit Committee
- Member of the Board of Directors
- Member of the Nominating and Governance Committee
- Director, 1 - 800 - FLOWERS.COM
- Member of Committee
Mr. McCann is the founder and Chairman of the board of directors of 1-800-FLOWERS.COM, Inc., a floral and gourmet foods gift retailer and distribution company founded in 1976, and served as chief executive officer of 1-800-FLOWERS.COM, Inc. from 1976 until June 2016. Mr. McCann also serves on the board of directors of International Game Technology PLC and has previously served on the board of directors of Willis Towers Watson PLC and The Scotts Miracle-Gro Company.
Job Titles:
- Chairman of the Nominating and Governance Committee
- Member of the Audit Committee
- Member of the Board of Directors
- Chairman at Kleiner Perkins
- Member of Committee
- Partner at Kleiner Perkins Caufield & Byers
John Doerr is Chairman at Kleiner Perkins, a venture capital firm, since 1980. Mr. Doerr currently serves on the board of directors of Alphabet and DoorDash. He previously served as a director of Amazon, Bloom Energy, Coursera, Quantumscape and Zynga Inc. Mr. Doerr holds a Bachelor of Science and a Master of Science in Electrical Engineering degrees from Rice University and a Master of Business Administration degree from Harvard University.
Chair of the Nominating and Governance Committee
Job Titles:
- Chief Executive Officer
- Member of the Board of Directors
- President
John Melo has 30 years of combined experience as an entrepreneur and thought leader in developing and growing technology companies and as a senior executive in the Oil & Gas industry. As President and Chief Executive Officer, Mr. Melo has led Amyris through successful technology development, industrial start up, product development and commercialization and a series of funding rounds, including the initial public offering. Before joining Amyris in 2007, Mr. Melo served in various senior executive positions at BP Plc (formerly British Petroleum) most recently as President of U.S. fuels operations where he successfully led a business transformation and significantly improved the financial performance. During his tenure at BP, Mr. Melo also served as Chief Information Officer of the refining and marketing segment; Senior Advisor for e-business strategy to Lord Browne, BP group chief executive; and Director of global brand development. In this last role, he helped develop the "Helios" re-branding effort. Before joining BP, Mr. Melo was with Ernst & Young. Mr. Melo currently serves on the board of directors of Renmatix Inc., serves on the board of directors of BayBio, serves on the Bio Industrial and Environmental section governing board, is a member of the Council for the Portuguese Diaspora and is a member of Young Presidents' Organization (YPO). He was formerly an appointed member to the U.S. section of the U.S.-Brazil CEO Forum. When not working on the mission of making sustainable chemistry mainstream or championing the eradication of malaria, John enjoys skiing, reading and time with his family on the island of Pico in the Azores, his childhood home.
Job Titles:
- Member of the Audit Committee
- Member of the Board of Directors
- Member of the Nominating and Governance Committee
- Senior Executive
- Chief Marketing & Communications Officer at Trinity Health
- Member of Committee
Julie Spencer Washington is an accomplished senior executive with a distinguished career in marketing spanning leading companies like Trinity Health, Champion Petfoods, Procter & Gamble, Gillette, Nestlé Purina, Jamba Juice, and Luxottica. In each of her leadership positions, Julie has driven sustainable corporate growth and profitability through a keen understanding of consumer needs and behaviors, market dynamics and digital trends (including social media). Julie has also leveraged her special gift for developing and motivating high-performing teams to further impact corporate success.
Currently, Julie serves as Chief Marketing & Communications Officer at Trinity Health, a Catholic health care delivery system that serves more than 30 million people across 22 states. She is responsible for the strategic leadership of marketing, brand building, demand creation, internal and crisis communications and community engagement.
Julie is committed to community improvement and, in parallel with her professional responsibilities, has a long, varied history of board service. She currently serves on the board of directors of Union Institute and University. Julie's professional and community accomplishments have earned national attention, including selection of Black Enterprise's "Top Women Executives in Advertising & Marketing " (2016 and 2013), Savoy magazine's "Top 100 Most Influential Blacks in Corporate America" (2020, 2018 and 2010), and Marketers That Matter's "Top B2C Marketing Executive of the Year" (2013).
Julie holds a Master of Business Administration degree from Washington University, a Bachelor of Arts degree in Chemistry and Psychology from Emory University, and an Executive in Education Certificate on Driving Digital and Social Strategy from Harvard University. A champion of diversity and inclusion, Julie has helped companies build more effective teams.
Job Titles:
- President
- President Amyris International
Lee joined Amyris as President, Amyris International in March, 2022. Prior to joining Amyris, Lee spent the majority of his career at Walmart where he served as President and Chief Executive Officer, Walmart Canada, after holding a number of global leadership roles with the company, including Chief Merchandising Officer with Walmart Japan and Vice President of Merchandising for the International Division.
With over 25 years of retail experience spanning Europe, Asia and North America, Lee has a proven track record of delivering results within highly competitive and innovative retail markets. He has a wealth of experience in operational and C-Suite roles across supply chain, store operations, and commercial functions with full end to end accountability.
Job Titles:
- Member of the Audit Committee
- Member of the Board of Directors
- Member of the Nominating and Governance Committee
- Member of Committee
Elected 2019 Lisa has pioneered the development of feminine Chinese brands for Daling Family. She partnered with former Estee Lauder CTO, Harvey Gedeon and award-winning Harvard Medical School skin management expert Dr. Rothaus, founding La Nature Research Center in New York. Together they created the Native Beauty skin wellness line. With Rosa Dwyer, ex-chief of formula for Estée Lauder Group, she developed Color Lock - a wellness line specially formulated for Chinese women's skin. Prior to Daling, Lisa served as Brand Director of Dupont Lycra (Hong Kong & China) and lead it to its current top-of-market position in China. She then served as the youngest Chief Representative of YSL China in France in the company's history. Member of the Nominating and Governance Committee
Job Titles:
- President of Aprinnova
- President, Consumer Accelerator
Mike Rytokoski joined Amyris as President of Aprinnova in June 2021. He brings over 30 years of international experience leading and growing businesses in Europe, Asia, North America and Latin America. Most recently Rytokoski served as Vice President, Chief Marketing Officer for Europe, Middle East and Africa at Goodyear. Prior to that, he led Goodyear's passenger vehicle and SUV tire business in Asia Pacific based in Shanghai driving significant expansion in both B2C and B2B.
Previously Rytokoski served as President and Chief Executive Officer for Asia and Latin America at The Clorox Company, a leading home care products manufacturer. In addition to cleaning brands, his portfolio at Clorox included Burt's Bees natural beauty care products. He started his career at Unilever working in marketing roles of increasing responsibility in the beauty category in Europe and Latin America.
Rytokoski holds an MBA from Helsinki School of Economics and has completed executive programs at Harvard and Wharton Business Schools. He serves as chairman of the board at Secapp, a Finnish SaaS company.
Mike joined Amyris as Vice President and General Manager of Pipette in July 2022. He prides himself on being a full-stack marketer and GM with a passion for building purpose-driven lifestyle brands. Over the last 15+ years, he has successfully created and accelerated business strategies and brand building efforts for The Honest Company, Red Bull, Planters, and Oscar Mayer with broad oversight touching all areas of the marketing mix. Prior to joining Amyris, Mike oversaw the personal care and household categories at The Honest Company where he led explosive omni-channel growth culminating in the company's Initial Public Offering (IPO). Mike holds an MBA from The Ohio State University as well as a B.S. in Consumer Science from the University of Wisconsin. He lives in Los Angeles with his wife, and is a proud father of two young daughters. #girldad
Job Titles:
- Member of the Audit Committee
- Member of the Board of Directors
- DSM in 2011 As Executive Vice - President, Corporate Strategy & Acquisitions
Mr. Eykerman joined DSM in 2011 as Executive Vice-President, Corporate Strategy & Acquisitions. In this role, he was responsible for corporate and business group strategy development, budgeting and planning, improvement programs, and all M&A activities. In 2015, he was also appointed as a member of the DSM Executive Committee and at present (and to-be in the context of the merger) is the President of the Health, Nutrition & Care business of DSM-Firmenich while maintaining the responsibility for the DSM-Firmenich M&A activities. Next to these roles within DSM-Firmenich, he is also a Supervisory Board member of ChemicaInvest (DSM/CVC JV), and a Supervisory Board member of AnQore TopCo B.V. Before joining DSM, Mr. Eykerman worked for 14 years at McKinsey & Company of which the last 9 year as a Partner and leader of McKinsey's Chemicals Practice in the Benelux and France. He holds a master degree in Chemical Engineering from the KU Leuven (Belgium) and in Refinery Engineering from the Institut Francais du Pétrole (France).
Job Titles:
- Independent Director
- Member of the Board of Directors
- Chairman of the Audit Committee Member of the Leadership, Development, Inclusion and Compensation Committee
- Partner at Foris Ventures
Ryan Panchadsaram is a partner at Foris Ventures and serves as an advisor to the Chairman at Kleiner Perkins. He has been in the role since 2016 and invests in bold founders and disruptive technologies that are tackling the climate crisis, fixing our healthcare system, and improving the way we live and work. Prior to Kleiner Perkins, Mr. Panchadsaram worked at the White House and served as the deputy chief technology officer for the United States. He helped shape how an $80 billion IT budget could be used by federal agencies to deliver on their missions in a more effective, user-centric, and datadriven way. In 2015, he served as a delegate to the United Nations to launch the Solutions Summit, a grassroots effort to spotlight the work of exceptional innovators around the world tackling the Sustainable Development Goals. In 2013, he was part of the crisis response team that rescued HealthCare.gov.
This was a multi-month effort that ultimately led to the Affordable Care Act providing healthcare to 31 million people. Prior to government service, he was a health technology entrepreneur and worked at Microsoft and Salesforce.com. Mr. Panchadsaram holds a Bachelor of Science degree in Industrial Engineering and Operations Research from U.C. Berkeley.
Job Titles:
- VP Global Brand Marketing & Engagement
Sola brings 17 years of Brand Marketing and Communications experience in travel, design, and finance to Amyris. She has a track record of advancing craft, innovation, and culture primarily within companies at the forefront of radically transforming societal and cultural norms.
Most recently, she served as a Director of Brand Strategy for Robinhood instituting the brand foundations needed for the company to make finance more accessible to a new generation of investors. Prior to this, she was the Head of Airbnb's Design Brand Marketing and Communications Group, a team focused on forging the company's creative identity at its infancy, building its global design community, and scaling its creative and learning culture. During her tenure, she played a pivotal role in establishing design as a strategic differentiator for the company, a key contributing factor to its successful IPO in 2020. She holds a B.A. in Communications and Journalism from the University of Virginia Tech. She also serves as an advisor to the Institute of Black Imagination.
Job Titles:
- Chairman of the Audit Committee
- Member of the Board of Directors
- Member of Committee
Elected 2018 Mr. Mills has more than 40 years of experience in the fields of accounting, corporate finance, strategic planning, risk management, and mergers and acquisitions. He served as Chief Financial Officer of the Company from May 2012 to December 2013. Prior to joining the Company, Mr. Mills had a 33-year career at Archer-Daniels-Midland Company ("ADM"), one of the world's largest agricultural processors and food ingredient providers. At ADM, he held various senior executive roles, including Chief Financial Officer, Controller, and head of Global Strategic Planning. Since 2013, Mr. Mills has served as a consultant and advisor to clients in the private equity, agribusiness, and financial services fields. Mr. Mills currently serves on the boards of Black Hills Corporation (where he serves as chair of the board), Farmers Edge, Inc., Illinois College (where he also serves as Chair of the board), First Illinois Corporation (along with its wholly-owned banking subsidiary, Hickory Point Bank & Trust) and Arianna S.A. Mr. Mills holds a Bachelor of Science degree in Mathematics from Illinois College. Chair of the Audit Committee Member of the Leadership, Development, Inclusion and Compensation Committee
Job Titles:
- Chief Science Officer & Head of R & D
Sunil Chandran leads Amyris research and development including collaborations as Chief Science Officer & Head of Research & Development. Previously, he was appointed Senior Vice President of Research and Development in 2019. With more than 15 years of experience in industrial biotechnology, he has a proven track record of bringing multiple biotech products to market. Since joining Amyris in 2006, Sunil has led multiple metabolic engineering focused projects, and was the primary architect of our world-class Automated Strain Engineering (ASE) platform. Notably in 2015, Sunil was the principal investigator who led an ambitious project that earned Amyris a $35 million Technology Investment Agreement from the US Defense Advanced Research Projects Agency (DARPA). Prior to joining Amyris, Sunil was a scientist at Kosan Biosciences, where he studied the ability of polyketide synthases to make novel pharmaceutical drug candidates. He has more than 20 published scientific papers, book chapters, and patents and has been an invited speaker at numerous international conferences on biotechnology. He holds a BS in chemistry from the University of Mumbai, an MS in chemistry from the Indian Institute of Technology, Mumbai, and a Ph.D. in chemistry from Michigan State University. Sunil also completed a post-doctoral fellowship in chemistry and biochemistry at the University of Wisconsin-Madison.
Teresa joined Amyris February 2017 and led the launch of Biossance at Sephora. She drove rapid growth for the brand as the VP of Marketing and Brand Strategy from 2017 to 2020. She became VP/GM of JVN in 2021 and led the launch of the brand from concept to inception in a record-breaking 9 months. Within its first year, JVN is already one of the leading haircare brands in North America.
Prior to Amyris, Teresa led Digital and Brand Marketing at ipsy and Retention Marketing at Sephora. She has a dual BA in Business Administration and Psychology with Honors from the University of Texas at Austin and an MBA from the Kellogg School of Management from Northwestern University.